The Nuclear Imaging Equipment Market, estimated at USD 3.57 Bn in 2025, is expected to exhibit a CAGR of 5.1% and reach USD 5.06 Bn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
Key market players are focusing on adoption of growth strategies such as launch of new products, and this is expected to drive the global nuclear imaging equipment market growth. For instance, on June 12, 2025, Siemens Healthineers, a Germany-based company that provides healthcare solutions and services, introduced Symbia Pro.specta, a single photon emission computed tomography/computed tomography (SPECT/CT) system with CE mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging technologies.
Global Nuclear Imaging Equipment Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems regarding transportation of things from one place to another.
COVID-19 had a negative impact on the global nuclear imaging equipment market. For instance, on April 6, 2025, according to the data published by the National Center for Biotechnology Information (NCBI), hospital patient volumes decreased during the beginning stages of the pandemic in multiple medical disciplines including radiology, emergency, and surgery departments. The American Hospital Association estimated that between March and June 2025, American hospitals lost on average US$ 50.7 billion per month. The decrease in overall patient volumes led to decreased need for imaging within hospital systems. Consequently, both imaging volumes and revenue generation were lower during the initial stages of the COVID-19 pandemic.
Global Nuclear Imaging Equipment Market: Key Developments
On October 16, 2025, GE Healthcare, a company that offers diagnostics, therapeutics and monitoring through intelligent devices, data analytics, decision support tools, introduced Omni Legend, first of its kind all digital PET-CT sytem, to drive efficiency, enhance diagnostics, and deliver on precision medicine.
Browse 35 Market Data Tables and 36 Figures spread through 180 Pages and in-depth TOC on “Global Nuclear Imaging Equipment Market”- Forecast to 2032, Global Nuclear Imaging Equipment Market, By Product Type (Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Hybrid PET-CT, Hybrid SPECT-CT, Hybrid PET-MRI, and Others), By Application (Oncology, Cardiology, Neurology, and Others), By End User (Hospitals and Clinics, Diagnostic Imaging Centers, Research Institutes, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).
Link: https://www.coherentmarketinsights.com/market-insight/nuclear-imaging-equipment-market-2366
Key Takeaways of the Global Nuclear Imaging Equipment Market:
- Global nuclear imaging equipment market is expected to exhibit a CAGR of 5.1% during the forecast period. The merger with emerging economies offers lucrative growth opportunities for players in the global nuclear imaging equipment market.
- Among application, the oncology segment is expected to hold a dominant position in the global nuclear imaging equipment market during the forecast period due to increasing prevalence of cancers globally. For instance, according to the data published by the American Cancer Society in 2025, 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2025 globally.
- Among region, North America is expected to be the dominant region in the global nuclear imaging equipment market, owing to the key players focusing on organic strategies to launch new product. For instance, on June 12, 2025, Siemens Healthineers, a Germany-based company which provides healthcare solutions and services, announced that the U.S. Food and Drug Administration (FDA) had approved Symbia Pro.specta, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with advanced CT and SPECT imaging technologies.
- Major players operating in the global nuclear imaging equipment market are GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Mediso Medical Imaging Systems, MIE America, DDD Diagnostic, Segami, and Digirad
Contact Us